Extracorporeal photopheresis (ECP) is effective in conditions with opposing immune etiology. ECP induces an immunomodulatory response through simultaneous monocyte activation and apoptosis induction of lymphocytes. However, ECP is also immunosuppressive, downregulating proinflammatory cytokines. Signal transducers and activators of transcription (STATs) are important mediators of cell-signaling systems, including cytokines. Ultraviolet (UV) immunosuppression is linked to reductions in cytokine-induced STAT phosphorylation.
Objective
The aim of this study was to find whether ECP downregulates STAT phosphorylation.
Methods
Pre- and post-ECP mononuclear cells from cutaneous T-cell lymphoma and chronic graft-versus-host disease patients were stimulated with either IFNγ, IL2, or IL15. The percentage of IFNγ-stimulated monocytes positive for phosphorylated STAT-1 (pSTAT-1) and the number of IL2- and IL15-stimulated T cells expressing phosphorylated STAT-5 (pSTAT-5) were determined at 0 and 24 h.
Results
Post-ECP, pSTAT-1 levels in monocytes remained unchanged; however, at 24 h post-ECP the number of T cells expressing pSTAT-5 was reduced.
Conclusion
Following ECP, monocytes retain their ability to phosphorylate STAT-1, while pSTAT-5 expression is lost in lymphocytes. This differential effect of ECP may account for the diverse population of diseases that benefit.
Get full access to this article
View all access options for this article.
References
1.
EdelsonR, BergerC, GasparroF, . Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: Preliminary results. N Engl J Med1987; 316:297–303.
2.
RichterHI, StegeH, RuzickaT, . Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. J Am Acad Dermatol1997; 36:787–789.
3.
OwsianowskiM, GollnickH, SiegertW, . Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant1994; 14:845–848.
4.
DiamandidouE, CohenPR, KurzockR. Mycosis fungoides and Sezary syndrome. Blood1996; 88:2385–2409.
5.
VowelsBR, LessinSR, CassinM, . Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol1994; 103:669–673.
6.
OchsLA, BlazarBR, RorJ, . Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant1996; 17:1085–1092.
PerezM, EdelsonRL, LarocheL, . Inhibition of antiskin allograft immunity by infusion with syngenic photoinactivated effector lymphocytes. J Invest Dermatol1989; 92:669–676.
9.
GottliebSL, WolfeJT, FoxFE, . Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a single institution. J Am Acad Dermatol1996; 35:946–957.
10.
ZouboulisCC, SchmuthM, DoepfmerS, . Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes. Dermatology1998; 196:305–308.
11.
YooEK, RookAH, ElenitsasR, . Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol1996; 107:235–242.
12.
BladonJ, TaylorPC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T ceil lymphoma and graft versus host disease patients. Br J Haematol1999; 107:707–711.
13.
HanlonDJ, BergerCL, EdelsonRL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int J Cancer1998; 78:70–75.
14.
BergerCL, XuAL, HanlonD, . Induction of human tumor-loaded dendritic cells. Int J Cancer2001; 91:438–447.
15.
TokuraY, SeoN, YagiH, . Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol1999; 113:202–208.
16.
VowelsBR, CassinM, BoufalMH, . Extracorporeal photochemotherapy induces the production of tumour necrosis factor-oc by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol1992; 98:686–692.
17.
HoriK, EhrkeMJ, MaceK, . Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and γ-interferon. Can Res1987; 47:5868–5874.
18.
SeoN, TokuraY, MatsumotoK, . Tumor-specific cytotoxic T-lymphocyte activity in Th2 type-Sezary syndrome: its enhancement by interferon-γ and interleukin-12 and fluctuations in association with the disease activity. Clin Exp Immunol1998; 112:403–409.
19.
KrengerW, FerraraJL. Dysregulation of cytokines during graft-versus-host disease. J Hematother1996; 5:3–14.
20.
XunCQ, ThompsonJS, JenningsCD, . Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H2-incompatible transplanted SCID mice. Blood1994; 83:2360–2367.
21.
StorbR, DeegHJ, WhiteheadJ, . Methotrexate and cyclosporine compared with cyclosporine alone for the prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med1986; 314:729–735.
22.
NeunerP, CharvatB, KnoblerR, . Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A. Photobiol Photochem1994; 59:182–188.
23.
BladonJ, TaylorPC. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Apheresis2002; 17:177–182.
24.
BladonJ, TaylorPC. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc2003; 35:1328–1332.
25.
KlosnerG, TrautingerF, KnoblerR, . Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Thl to a Th2 response. J Invest Dermatol2001; 116:459–462.
26.
LimCP, CaoX. Serine phosphorylation and negative regulation of Stat3 byJNK. J Biol Chem1999; 274:31055–31061.
MudterJ, NeurathMF. The role of signal transducers and activators of transcription in T inflammatory bowel diseases. Inflam Bowel Dis2003; 9:332–337.
29.
BattleTE, FrankDA. The role of STATs in apoptosis. Curr Mol Med2002; 2:381–392.
30.
GermainRN, MarguliesDH. The biochemistry and cellular biology of antigen processing and presentation. Annu Rev Immunol1993; 11:403–450.
31.
Muhlethaler-MottetA, OftenLA, SteimleV, . Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J1997; 16:2851–2860.
32.
Muhlethaler-MottetA, Di BerardinoW, OftenLA, . Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Statl and USF-1. Immunity1998; 8:157–166.
33.
MorigglR, TophamDJ, TeglundS, . Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity1999; 10:249–259.
34.
KulmsD, SchwarzT. Ultraviolet radiation inhibits interleukin-2-induced tyrosine phosphorylation and the activation of STAT5 in T lymphocytes. J Biol Chem2001; 276:12849–12855.
35.
PericleF, KirkenRA, BronteV, . Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. J Immunol1997; 159:2580–2585.
36.
AraganeY, KulmsD, LugerTA, . Down-regulation of interferon γ-activated STAT1 by UV light. Proc Natl Acad Sci USA1997; 94:11490–11495.
37.
SteimleV, SiegristCA, MottetA, . Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science1994; 265:106–109.
38.
LdeBarbara A, TosiG, FrumentoG, . Block of Stat-1 activation in macrophages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation. Eur J Immunol2002; 32:1309–1318.
39.
WolfeJT, LessinSR, SinghAH, . Review of immunomodulation by photopheresis: Treatment of cutaneous T cell lymphoma, autoimmune disease and allograft rejection. Artif Organs1994; 18:888–897.
40.
ItoS, AnsariP, SakatsumeM, . Interleukin-10 inhibits expression of both interferon a- and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood1999; 93:1456–1463.
41.
MarodiL, GodaK, PaliczA, . Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-γ. Clin Exp Immunol2001; 126:456–460.
42.
FujiharaM, TakahashiTA, AzumaM, . Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: Its involvement in inactivation of allogenecity. Blood1996; 87:2386–2393.
43.
RattisFM, ConchaM, Dalbiez-GauthierC, . Effects of ultraviolet B radiation on human Langerhans cells: functional alterations of CD86 upregulation and induction of apoptotic cell death. J Invest Dermatol1998; 111:373–379.
44.
TamburAR, OrtegelJW, MoralesA, . Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc2000; 32:747–748.
45.
BladonJ, TaylorPC. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes. J Photochem Photobiol B2003; 69:129–138.
46.
MaziereC, DantinF, DuboisF, . Biphasic effect of UVA radiation on STAT1 activity and tyrosine phosphorylation in cultured human kerantinocytes. Free Radic Biol Med2000; 28:1430–1437.
47.
FrenchLE, AlcindorT, ShapiroM. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. Bone Marrow Transplant2002; 30:509–515.
48.
NakajimaH, LiuXW, Wynshaw–BorisA, . An indirect effect of Stat5a in IL-2-induced proliferation: a crucial role of Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity1997; 7:691–701.
49.
BianchiM, MengC, IvashikivLB, . Inhibition of IL-2 induced Jak/STAT signalling by glucocortoids. Proc Natl Acad Sci USA2000; 97:9573–9578.
50.
OwenCM, HarrisonPV. Successful treatment of severe psoriasis with basiliximab, an interleukin 2 receptor monoclonal antibody. Clin Exp Dermatol2000; 25:195–197.
51.
MrowietzU, ZhuK, ChristophersE. Treatment of severe psoriasis with anti-CD25 monoclonal antibodies. Arch Dermatol2000; 136:675–676.
52.
TakemotoS, MulloyJC, CeresetoA, . Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA1997; 94:13897–13902.
53.
FranchiniG. Molecular mechanisms of human T-cell leukemia/lymphotrppic virus type I infection. Blood1995; 86:3619–3639.
54.
NicotC, MulloyJC, FerrariMG, . HTLV-1 p12Iproteins enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood2001; 98:823–829.
55.
ZamoranoJ, WangHY, WangR, . Regulation of cell growth by IL2: Role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol1998; 160:3502–3512.
